Section I: Introduction to Pharmacology
e e e e
1. The Nursing Process and Patient-Centered Care
e e e e e
2. Drug Development and Ethical Considerations
e e e e
3. Pharmacokinetics and Pharmacodynamics e e
4. Pharmacogenetics
5. Complementary and Alternative Therapies e e e
6. Pediatric Considerations e
7. Older Adult Considerations
e e
8. Drugs in Substance Use Disorder
e e e e
Section II: Pharmacotherapy and Drug Administration
e e e e e
9. Safety and Quality
e e
10. Drug Administration
e
11. Drug Calculations
e
Section III: Maintenance of Homeostasis
e e e e
12. Fluid Volume and Electrolytes
e e e
13. Vitamin and Mineral Replacement e e e
14. Nutritional Support e
Section IV: Autonomic Nervous System Drugs
e e e e e
15. Adrenergic Agonists and Antagonists e e e
,16. Cholinergic Agonists and Antagonists
e e e
Section V: Central and Peripheral Nervous System Drugs
e e e e e e e
17. Stimulants
18. Depressants
19. Antiseizure Drugs e
20. Drugs for Parkinsonism and Alzheimer‘s Disease
e e e e e
21. Drugs for Neuromuscular Disorders and Muscle Spasms
e e e e e e
Section VI: Mental and Behavioral Health Drugs
e e e e e e
22. Antipsychotics and Anxiolytics e e
23. Antidepressants and Mood Stabilizers e e e
Section VII: Pain and Inflammation Management Drugs
e e e e e e
24. Antiinflammatories
25. Analgesics
Section VIII: Antimicrobial Drugs
e e e
26. Antibacterials
1. Section A: Penicillins and Cephalosporins
e e e e
2. Section B: Macrolides and Tetracyclines
e e e e
3. Section C: Aminoglycosides and Fluoroquinolones
e e e e
4. Section D: Sulfonamides and Metronidazole
e e e e
27. Antituberculars, Antifungals, and Antivirals e e e
28. Antimalarials, Anthelmintics, and Peptides
e e e
, Section IX: Immunologic Drugs
e e e
29. HIV- and AIDS-Related Drugs
e e e
30. Transplant Drugs e
31. Vaccines
Section X: Antineoplastics and Biologic Response Modifiers
e e e e e e
32. Anticancer Drugs e
33. Targeted Therapies to Treat Cancer
e e e e
34. Biologic Response Modifiers
e e
Section XI: Respiratory Drugs
e e e
35. Upper Respiratory Disorders
e e
36. Lower Respiratory Disorders
e e
Section XII: Cardiovascular Drugs
e e e
37. Cardiac Glycosides, Antianginals, and Antidysrhythmics
e e e e
38. Diuretics
39. Antihypertensives
1. Section A: Beta Blockers
e e e
2. Section B: Alpha Blockers
e e e
3. Section C: Drugs Affecting RAAS
e e e e
4. Section D: Calcium Channel Blockers
e e e e
40. Anticoagulants, Antiplatelets, and Thrombolytics
e e e
41. Antihyperlipidemics and Drugs to Improve Peripheral Blood e e e e e e